741338
Last Update Posted: 2014-07-02
Recruiting has ended
All Genders accepted | Under 5 Years |
7 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Immune Tolerance Study With Aldurazyme® (Laronidase)
The purpose of this study is to see if treatment with an antigen-specific immunosuppressive can decrease or stop an antibody response to laronidase (Aldurazyme®) during enzyme replacement therapy with laronidase in severe Mucopolysaccharidosis I (MPS I) participants.
Eligibility
Relevant conditions:
Mucopolysaccharidosis I
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov